Optimizing Clinical and Economic Outcomes of Surgical Therapy for Patients with Colorectal Cancer and Synchronous Liver Metastases
- 7 May 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 215 (2), 262-270
- https://doi.org/10.1016/j.jamcollsurg.2012.03.021
Abstract
Background Traditionally, for patients with colorectal cancer with resectable synchronous liver metastases, resections were performed separately. However, the safety and efficacy of simultaneous resection have been demonstrated in selected patients. The purpose of this study was to evaluate outcomes and economic implications of simultaneous and staged resections. Study Design We conducted a retrospective cohort study of consecutive colorectal cancer patients with resectable synchronous liver metastases treated between 1993 and 2010, constructing a decision tree comparing simultaneous and staged resections. For generalizability, the analysis was conducted from a payer perspective, using costs derived from 2010 Medicare reimbursement. Decision models incorporated the severity-refined DRG complications (complicating condition/major complicating condition) modifiers. Sensitivity analyses used alternative models of DRG reimbursement. Results There were 144 patients analyzed. Sixty (41.7%) underwent simultaneous resection and 84 (58.3%) underwent staged resection. Median overall survival did not differ between the simultaneous and the staged cohorts (66.3 vs 65.6 months, respectively), nor did the overall complication rate (38.3% vs 40.5%, respectively). Median total length of hospitalization was significantly shorter in the simultaneous cohort (8 vs 14 days; p = 0.001). In the base model, the simultaneous strategy cost less than the staged strategy ($20,983 vs $25,298 per case)—a savings of 17.1%. Sensitivity analyses examining alternative severity-refined DRG reimbursements demonstrated potential cost savings, in all but 1 extreme sensitivity analysis, ranging from 9.8% to 27.3% favoring simultaneous resection. Conclusions The simultaneous resection strategy was oncologically equivalent and more cost efficient for patients with primary colorectal cancer presenting with resectable liver metastases. A reduction in overall length of hospital stay was an associated benefit. Future studies should explore the feasibility and clinical implications of policies to maximize the potential for simultaneous resection in this cohort of patients.Keywords
This publication has 20 references indexed in Scilit:
- Hospital Characteristics Associated with Failure to Rescue from Complications after PancreatectomyJournal of the American College of Surgeons, 2010
- Hospital characteristics, clinical severity, and outcomes for surgical oncology patientsSurgery, 2010
- National and Surgical Health Care Expenditures, 2005–2025Annals of Surgery, 2010
- Consensus Guidelines in the Management of Branch Duct Intraductal Papillary Mucinous Neoplasm: A Cost-Effectiveness AnalysisDigestive Diseases and Sciences, 2009
- Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional AnalysisAnnals of Surgical Oncology, 2007
- Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidismSurgery, 2006
- Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasisJournal of the American College of Surgeons, 2003
- Simultaneous resection of colorectal primary tumour and synchronous liver metastasesBritish Journal of Surgery, 2003
- Cost-Effectiveness of Hepatic Metastasectomy in Patients With Metastatic Colorectal CarcinomaAnnals of Surgery, 2003
- Surgeon volume as an indicator of outcomes after carotid endarterectomy: An effect independent of specialty practice and hospital volumeJournal of the American College of Surgeons, 2002